About SHAPE  SHAPE Professional Site       

 
What You Should Know SHAPE Your Heart Get Involved Donate Home

 News / Headlines

   

News / Headlines

 

Contact: Daniel Keeney, APR
DPK Public Relations
832.467.2904
dan@dpkpr.com



SHAPE Welcomes New ACC/AHA Risk Assessment Guidelines

 


HOUSTON, November 15, 2010 – SHAPE is participating this week at the American Heart Association 2010 Scientific Sessions in Chicago. There have been a number a major developments, including the release of the "2010 guideline for assessment of cardiovascular risk in asymptomatic adults," by the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) Task Force on Practice Guidelines in collaboration with six other specialty societies. This is a very welcome release and it closely matches the First SHAPE Guideline that we released in 2006. We expect to have more to say about this in the coming days.

The coverage in theheart.org focuses in on the differences, but the fact is that the new ACC/AHA risk assessment guidelines represent a giant step toward the widespread adoption of scientifically proven technologies that can accurately assess an individual’s risk of a first heart attack. See theheart.org story by Reed Miller, “Dueling advice: New ACC/AHA risk assessment guidelines, SHAPE II released on same day”: http://www.theheart.org/article/1148755.do

 


About the Society for Heart Attack Prevention and Eradication (SHAPE):
The mission of SHAPE (www.shapesociety.org) is to eradicate heart attack by championing new strategies for prevention while advancing the scientific quest for a cure. SHAPE visualizes a world free from the threat of heart attack. The goals of SHAPE are to reduce the instances of heart attack - especially in the asymptomatic patient - through education programs presented to both healthcare professionals and the community. SHAPE believes that education and ongoing research are key elements in the success of programs designed to go beyond the norm in the early detection and treatment of cardiovascular disease.

 

 

 

 

 

 

 

 

 

 

 

 

Contact